You are here:

Ciclesonide (Alvesco®)

Advice

Following a full submission:

Ciclesonide (Alvesco®) is accepted for restricted use within NHS Scotland for the prophylactic treatment of persistent asthma in adults (18 years and older).

Ciclesonide is restricted to asthma patients who require once a day administration and whose treatment is at step 2 or step 3 of the British Guideline on the Management of Asthma.

Alternative inhaled steroids are available at lower costs

Drug Details

Drug Name: Ciclesonide (Alvesco®)
SMC Drug ID: 184/05
Manufacturer: Altana Pharma Ltd
Indication: Prophylactic treatment of persistent asthma in adults (18 years and older)
BNF Category:
Sub Category: 3.2 Corticosteroids
Submission Type: Full submission
Status: Restricted
Date Advice Published: 11 July 2005

Back